Germany· DE-A57-1aac495625ffa144
Doxepin Dura T Viatris Germany
A doxepin product containing doxepin hydrochloride, registered in Germany by Viatris Germany Gmbh. The same ATC class is registered in 9 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Doxepin is registered in 9 of 19 countries.
Countries holding a registration under ATC N06AA12 (doxepin), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 6 of them publish a price we can compare per daily dose
Doxepin · ATC N06AA12
9 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Germany
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Doxepin Hydrochloride
- Manufacturer
- Viatris Germany Gmbh
- Country
- Germany (DE)
- ATC code
- N06AA12
- ATC class
- Doxepin
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
932 interactions on record for doxepin.
Graded by severity as the source publishes them — 148 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Doxepin · interactions on record
932 records
- 148 severe
- 527 moderate
- 32 minor
- 148 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
77 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N06AA12
Doxepin, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f9b16e2a-c579-4f35-9bcb-195ae4b87664 GET /v1/drugs/f9b16e2a-c579-4f35-9bcb-195ae4b87664?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Doxepin Hydrochloride",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about doxepin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.